Today: 21 May 2026

Bitcoin traders cool on Fed rate cuts ahead of March meeting as Warsh uncertainty bites

Bitcoin traders cool on Fed rate cuts ahead of March meeting as Warsh uncertainty bites

Traders on Polymarket put an 83% chance on the Federal Reserve holding rates steady at its March 17-18 meeting, with CME FedWatch showing just 17% odds of a cut. Bitcoin fell 0.7% to $69,106 and ether dropped 0.9% as crypto markets adjusted to President Trump’s nomination of Kevin Warsh as Fed chair. Betting markets now expect two rate cuts in 2026, down from three.
10 February 2026
··
Kyndryl stock price steadies in premarket after 55% crash on SEC-linked review and delayed filing

Kyndryl stock price steadies in premarket after 55% crash on SEC-linked review and delayed filing

Kyndryl shares rose 0.4% premarket Tuesday after plunging 54.9% Monday, closing at $10.59. The company delayed its quarterly 10-Q, citing internal-control weaknesses and an SEC review of cash-management disclosures. CFO David Wyshner and the global controller exited as management reshuffled. J.P. Morgan downgraded the stock, citing uncertainty after the CFO change.
10 February 2026
·
Credo Technology stock jumps again in premarket after surprise revenue lift

Credo Technology stock jumps again in premarket after surprise revenue lift

Credo shares jumped 16.6% to $143.88 in premarket trading after the company projected fiscal Q3 revenue of $404 million to $408 million, well above prior guidance. The company flagged over 200% revenue growth for fiscal 2026 and expects mid-single-digit sequential growth into Q4. Full results are due March 2. The revenue figures are preliminary and unaudited.
10 February 2026
···
Oracle stock snaps back after OpenAI upgrade call — $50 billion fundraising looms

Oracle stock snaps back after OpenAI upgrade call — $50 billion fundraising looms

Oracle shares jumped 9.7% to $156.59 Monday after D.A. Davidson upgraded the stock, citing easing concerns over its OpenAI exposure. Oracle plans to raise up to $50 billion in 2026 through debt and equity, including a $20 billion at-the-market share program. Melius Research downgraded Oracle, warning of cash flow risks and competition from Anthropic and Google. Microsoft and Nvidia also posted gains Monday.
10 February 2026
···
Mortgage rates today: 30-year holds near 6% as borrowers chase scarce sub-6 deals

Mortgage rates today: 30-year holds near 6% as borrowers chase scarce sub-6 deals

The average 30-year fixed mortgage rate held at 5.99% on Feb. 9, according to Zillow, with little movement in recent weeks. Some lenders, including Navy Federal and Citi, still offered sub-6% rates, but terms varied. A Clever Real Estate survey found 94% of buyers would reconsider if rates rose above 6%. The Federal Reserve has no rate-setting meeting scheduled until March.
10 February 2026
··
Imperial Brands share price drops 1% as FTSE slips and dividend date nears

Imperial Brands share price drops 1% as FTSE slips and dividend date nears

Imperial Brands shares fell 1.1% to 3,258 pence in early London trading, near session lows, as tobacco stocks tracked a weaker FTSE 100. British American Tobacco dropped 1.5%. BP’s paused buybacks weighed on the market, sharpening focus on dividends and balance sheets. Investors are watching Imperial’s Feb. 19 ex-dividend date and upcoming trading update.
10 February 2026
·····
Compass Group share price stalls near 2026 low as AI worries keep CPG in focus

Compass Group share price stalls near 2026 low as AI worries keep CPG in focus

Compass Group shares slipped 0.14% to 2,078 pence in light Tuesday trading, after hitting a 2026 low last week. The company reaffirmed 2026 profit guidance and reported 7.3% organic revenue growth, but investor focus remains on AI risks and office catering demand. Compass will switch its London share trading currency to U.S. dollars on April 1. Half-year results are due May 11.
10 February 2026
··
ICG plc stock slips in London after Asia-Pacific strategy hire lands

ICG plc stock slips in London after Asia-Pacific strategy hire lands

ICG plc shares fell 1.1% to 1,701p in early London trading Tuesday after the firm named Sujey Subramanian as head of its Asia-Pacific Corporate strategy, effective May 1. Assets under management stood at $127 billion at end-December, with $36 billion in uninvested capital. The stock has traded between 1,695p and 1,725p so far in the session. Full-year results are due May 21.
10 February 2026
·
Vodafone share price rises again as buyback filing hits tape and Egypt spectrum plan comes into view

Vodafone share price rises again as buyback filing hits tape and Egypt spectrum plan comes into view

Vodafone shares rose 1.1% to 114.55 pence in early London trading after the company disclosed a new buyback and plans to acquire 1,800MHz spectrum in Egypt. Vodafone bought 23.39 million shares on Feb. 9, to be held in treasury. The Egypt spectrum payment will start with $100 million in FY26, totaling about $350 million. LBBW raised its price target to 120 pence, maintaining a “buy” rating.
10 February 2026
·
Experian share price slides after fresh buyback update, with May results now in focus

Experian share price slides after fresh buyback update, with May results now in focus

Experian shares fell 1.5% to 2,463 pence in early London trading Tuesday, near a one-year low, despite the company buying back 400,000 shares on Monday. The stock touched 2,436 pence, matching the 52-week bottom. Experian has repurchased over 2.4 million shares since launching its $1 billion buyback program on Jan. 30. Non-executive director Esther Lee also acquired 10.398 ADRs through dividend reinvestment.
10 February 2026
··
BAE Systems share price slips after $137m U.S. Army deal as earnings loom

BAE Systems share price slips after $137m U.S. Army deal as earnings loom

BAE Systems shares fell 0.7% to 1,930.0 pence in early London trading Tuesday after announcing a $137 million U.S. Army contract for missile-warning systems. The drop followed a 3.43% gain on Monday. Investors are awaiting BAE’s annual results on Feb. 18 for updates on guidance and cash returns. The company also repurchased 114,829 shares for cancellation on Feb. 6.
10 February 2026
··
1 … 289 290 291 292 293 … 1,961

Stock Market Today

  • Info Edge (India) (NSE:NAUKRI): Growth and Insider Ownership Highlight Potential
    May 20, 2026, 8:52 PM EDT. Info Edge (India) (NSE:NAUKRI) has posted a 19% compound annual growth in earnings per share (EPS) over three years and a 15% revenue increase to ₹32 billion. EBIT margins remained steady, indicating efficient cost management. Notably, insiders hold 43% of shares, aligning management interests with shareholders and limiting sudden sell-offs. While growth is promising, investors should consider market valuation and assess remuneration levels to ensure sustainable corporate governance. This Indian firm stands out as a profitable, growing company amid market volatility, potentially adding long-term value for shareholders.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop